Ben Tre Pharmaceutical Joint Stock Company (HOSE: DBT)
12,500
Open12,300
High12,600
Low12,300
Vol35,600
Market Cap.256.63
Remain Bid9,900
Remain Ask6,600
52Wk High13,700
52Wk Low10,600
52Wk Avg Vol10,707
Foreign Buy-
Frgn Owned(%)1.16
Dividend
Dividend Yield-
Beta0.54
EPS535
P/E23.19
F P/E10.61
BVPS13,932
P/B0.89
| Date | Close | Change | Volume |
|---|---|---|---|
| 07/15/2025 | 12,500 | 100 (+0.81%) | 35,600 |
| 07/14/2025 | 12,400 | 0 (0.00%) | 16,000 |
| 07/11/2025 | 12,400 | 0 (0.00%) | 9,000 |
| 07/10/2025 | 12,400 | 200 (+1.64%) | 4,500 |
| 07/09/2025 | 12,200 | 0 (0.00%) | 33,500 |
| 07/01/2025 | DBT: Signing an audit contract for the 2025 financial statements  |
| 06/05/2025 | DBT: Loan at MSB |
| 04/29/2025 | DBT: Change in personnel |
| 04/25/2025 | DBT: Minutes & Resolution of the 2025 AGM |
| 04/22/2025 | DBT: Annual Report 2024 |
| 07/05/2024 | DBT Dividend payment by share with 14.00% for 2023 (Record date) |
| 01/30/2023 | DBT Dividend payment by share with 10.00% for 2021 (Record date) |
| 02/19/2021 | DBT Dividend payment in cash with 7.00% for 2020 (Record date) |
| 02/19/2021 | DBT Dividend payment in cash with 7.00% for 2020 |
| 01/05/2021 | DBT Bonus share issue with 5.00% |
| 05/02/2025 | Parent Company FS Quarter 1 of 2025 |
| 05/02/2025 | Consolidated FS Quarter 1 of 2025 |
| 04/25/2025 | Resolution of Annual Shareholders' Meeting 2025 |
| 04/04/2025 | 2025 Annual Shareholders’Meeting Documents |
| 04/21/2025 | Annual report 2024 |
Name: Ben Tre Pharmaceutical Joint Stock Company
Abbreviation:Bepharco
Address: No.6A3 National Hightway 60, Phu Tan Ward Ben Tre Ben Tre
Telephone: (84.275) 822 429 - 813 447 - 829 528
Fax: (84.275) 824 248
Email:bepharco.vietnam@bepharco.com
Website:http://bepharco.com
Exchange: HOSE
Sector: Manufacturing
Industry: Chemical - Pharmaceutical
Listing date: 10/28/2020
Chartered capital: 205,306,500,000
Listed shares: 20,530,650
Shares outstanding: 20,530,650
Status: Operating
Tax code: 1300382591
Establishment license: 1541/QĐ-UB
Issued date: 05/06/2004
Business license: 1300382591
Issued date: 07/05/2004
Main business scope:
- Manufacturing and trading drugs which treat humans being diseases
- Importing and exporting end-product drug and packages.
- Trading medical machines and equipment.
- Trading functional foods.
- 1983: Ben Tre Pharmaceutical trust-company was established;
- 1992: Renamed as Pharmaceutical and Medical material company (Bepharco) with the capital of VND5.6 billion;
- 2004: Transformed into a joint stock company with a charter capital of VND20 billion;
- 2007: Increased the charter capital to VND30 billion;
- 2009: Listed on Hanoi Stock Exchange (HNX);
- October 01, 2019: Increased the charter capital to VND135,28 billion;
- October 20, 2020: Delisted from Hanoi Stock Exchange (HNX);
- Ocotber 28, 2020: Traded on Ho Chi Minh Stock Exchange (HOSE);
- February 03, 2021: Increased the charter capital to VND142,051,160,000;
- 12/22/2025 DBT Annoucement of the change of listing - 920,000 shares
- 12/12/2025 DBT Annoucement of the change of listing - 1,000,000 shares
- 04/24/2025 DBT General Meeting of Shareholders for 2025
- 02/11/2025 DBT Decision on the change of listing - 1,920,000 shares
- 08/20/2024 DBT Annoucement of the change of listing - 2,285,173 shares
| Items | Unit |
|---|---|
| Price | VND |
| Volume | Shares |
| Foreigner's, Yield | % |
| Mkt Cap | bVND |
| Financial indicators | mVND |
| EPS, BVPS, Dividend | VND |
| P/E, F P/E, P/B | Times |
| ROS, ROA, ROE | % |
2. F PE is taken from the estimates of earnings announced by listed companies.
3. 3-month/6-month/12-month price charts are compiled from revised data.
